Michael Scolaro

Michael Scolaro

Sep 23, 2017

Group 6 Copy 259
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

    We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

    Can people be screened for acute mountain sickness susceptibility?

    This project aims to investigate cerebral deoxygenation during exercise in hypoxia in order to highlight...

    Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

    The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals...

    Backer Badge Funded